Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy
- 1 January 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (3) , 217-221
- https://doi.org/10.1016/0002-9149(89)90288-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effects of antiserum against alpha-rat atrial natriuretic peptide in anesthetized rats.Hypertension, 1987
- Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardiaJournal of the American College of Cardiology, 1987
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Plasma alpha natriuretic peptide in cardiac impairment.BMJ, 1986
- Radioimmunoassay and Characterization of Atrial Natriuretic Peptide in Human Plasma*Journal of Clinical Endocrinology & Metabolism, 1986
- Atrial pressure and secretion of atrial natriuretic factor into the human central circulationJournal of the American College of Cardiology, 1986
- The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man.Circulation, 1986
- EFFECTS OF CHANGES IN DIETARY SODIUM INTAKE AND SALINE INFUSION ON IMMUNOREACTIVE ATRIAL NATRIURETIC PEPTIDE IN HUMAN PLASMAThe Lancet, 1985
- PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERSThe Lancet, 1985
- RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERSThe Lancet, 1985